Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-08-08 Purchase |
2024-08-08 7:43 pm |
TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director |
1,666 | $0 | $0 | 49,991 (Direct) |
View |
2021-11-23 Purchase |
2021-11-26 1:30 pm |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
20,000 | $2.4 | $48,000 | 3,180,465 (Indirect Direct) |
View |
2021-08-16 Purchase |
2021-08-17 12:38 pm |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
152,857 | $0.32469 | $49,631 | 363,213 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-21 Option Award |
2025-01-23 5:02 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
787,402 | $0 | 1,588,012 (Indirect) |
View |
2025-01-13 Option Award |
2025-01-14 6:50 pm |
N/A 2035-01-12 |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman |
45,000 | $0 | 45,000 (Direct) |
View |
2024-12-10 Option Award |
2024-12-12 8:07 pm |
2025-12-10 2034-12-10 |
TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director |
100,000 | $0 | 149,991 (Direct) |
View |
2024-01-04 Option Award |
2024-01-05 9:02 pm |
N/A 2034-01-03 |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman |
125,000 | $0 | 125,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 9:28 pm |
2023-06-09 2032-06-09 |
TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director |
5,000 | $0 | 12,495 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 6:58 pm |
2022-01-03 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
302,127 | $0 | 302,127 (Direct) |
View |
2021-08-17 Conversion |
2021-08-17 12:38 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
38,866,391 | $0 | 363,213 (Indirect) |
View |
Ownership |
2021-08-12 7:34 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T Pres., CEO and Chairman 10% Owner |
0 | $0 | 37,910,987 (Direct) |
View |
2021-06-10 Option Award |
2021-06-15 4:34 pm |
2022-06-10 2031-06-10 |
TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director |
5,000 | $0 | 5,000 (Direct) |
View |
2020-05-01 Option Award |
2020-05-15 5:01 pm |
2021-05-01 2030-05-01 |
TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director |
500 | $0 | 500 (Direct) |
View |